METASTATIC COLORECTAL CANCER (CRC)
Clinical trials for METASTATIC COLORECTAL CANCER (CRC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CANCER (CRC) trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER (CRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug cocktail targets Hard-to-Treat colorectal cancer
Disease control OngoingThis study tests a combination of three drugs (tiragolumab, atezolizumab, and bevacizumab) in people with a type of advanced colorectal cancer that has not responded to prior treatments. The goal is to see if the combo can shrink tumors or slow the disease. Participants receive t…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Mouth bacteria may predict colon cancer drug resistance
Knowledge-focused OngoingThis study examines if the amount of a bacteria called Fusobacterium nucleatum in colon cancer tumors is linked to how well patients respond to targeted therapies like cetuximab or panitumumab. Researchers will analyze stored tumor samples from 500 patients with metastatic colore…
Matched conditions: METASTATIC COLORECTAL CANCER (CRC)
Sponsor: Barretos Cancer Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC